Track the Navamedic ASA stock price and the full management transaction log of the company, a publicly traded company based in Norway. Shares are listed on the NO market, under the authority of Oslo Børs. Operating in the Health Care sector, Navamedic ASA has published 23 public disclosures. Market capitalisation: €376.5m. The latest transaction was disclosed on 26 June 2026 (Purchase). Among the most active insiders: Soleglad Invest AS. Every trade is free.
23
Insider Decl.
n/a
Thresholds
€67,956
17 ops.
Buy Volume
€29,381
3 ops.
Sell Volume
15Σ signal
Buys €67,956€29,381 Sells
Fundamental score
Ranked 22,709 of 29,053 companies
32.1
score / 100
Value
38
Quality
26
FCF yld6.6%
Earn yld-6.7%
EV/EBITDA19.1x
ROE-8.9%
Gross mgn39%
Net mgn-4.2%
Debt/EBITDA7.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Navamedic ASA is a Norwegian company focused on health and pharmaceuticals, providing pharmaceutical products and health solutions. It is listed on the Oslo Stock Exchange.